Pfm Health Sciences, LP Pacira Bio Sciences, Inc. Transaction History

Pfm Health Sciences, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$35.66 - $44.99 $26.2 Million - $33 Million	-734,346 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$36.57 - $47.97 $16.5 Million - $21.7 Million	452,149 Added 160.22%	734,346 $31.9 Million
Q1 2019 May 15, 2019	SELL	$36.47 - $42.17 $8.8 Million - $10.2 Million	-241,300 Reduced 46.09%	282,197 $10.7 Million
Q4 2018 Feb 14, 2019	SELL	$41.31 - $52.16 $93.9 Million - $119 Million	-2,274,077 Reduced 81.29%	523,497 $22.5 Million
Q3 2018 Nov 13, 2018	SELL	$32.85 - $52.0 $10.3 Million - $16.3 Million	-312,639 Reduced 10.05%	2,797,574 $138 Million
Q2 2018 Aug 14, 2018	BUY	$27.5 - $39.8 $38.7 Million - $55.9 Million	1,405,605 Added 82.46%	3,110,213 $99.7 Million
Q1 2018 May 15, 2018	BUY	$29.98 - $46.35 $51.1 Million - $79 Million	1,704,608 New	1,704,608 $53.1 Million

264

50.6M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $763M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Pfm Health Sciences, LP, based on Form 13F filings with the SEC.

Stay updated on Pfm Health Sciences, LP with notifications on news.